scispace - formally typeset
S

Shigeki Ohta

Researcher at Keio University

Publications -  47
Citations -  2241

Shigeki Ohta is an academic researcher from Keio University. The author has contributed to research in topics: Neural stem cell & Neurosphere. The author has an hindex of 21, co-authored 45 publications receiving 2017 citations. Previous affiliations of Shigeki Ohta include Osaka University & University of Calgary.

Papers
More filters
Journal ArticleDOI

Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination

TL;DR: Aged mice exhibited no differences from young adult mice in their ability to discriminate between two discrete odors but were significantly poorer at performing discriminations between similar odors, suggesting that the impairment in fine olfactory discrimination with age may result from a reduction in EGF-dependent Olfactory neurogenesis.
Journal ArticleDOI

Adrenomedullin Stimulates Two Signal Transduction Pathways, cAMP Accumulation and Ca2+ Mobilization, in Bovine Aortic Endothelial Cells

TL;DR: The results suggest that adrenomedullin elicits the hypotensive effect through at least two mechanisms, a direct action on vascular smooth muscle cells to increase intracellular cAMP and an action on endothelial cells to stimulate nitric oxide release, with both leading to vascular relaxation.
Journal ArticleDOI

Generation of Human Melanocytes from Induced Pluripotent Stem Cells

TL;DR: This in vitro differentiation system should prove useful for understanding human melanocyte biology and revealing the mechanism of various pigment cell disorders, including melanoma.
Journal ArticleDOI

Downregulation of KIF23 suppresses glioma proliferation.

TL;DR: Results indicate that downregulation of KIF23 decreases proliferation of glioma cells and that Kif23 may be a novel therapeutic target in malignant gliomas.
Journal ArticleDOI

Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.

TL;DR: Macrophage migration inhibitory factor (MIF) can induce NSPC proliferation and maintenance by multiple signaling pathways acting synergistically, and it may be a potential therapeutic factor, capable of activating NSPCs, for the treatment of degenerative brain disorders.